Mystery of Retinal Vein Occlusion: Vasoactivity of the Vein and Possible Involvement of Endothelin-1

Biomed Res Int. 2017:2017:4816527. doi: 10.1155/2017/4816527. Epub 2017 Aug 20.

Abstract

Retinal vein occlusion (RVO) is a common vascular disease of retina; however, the pathomechanism leading to RVO is not yet clear. In general, increasing age, hypertension, arteriosclerosis, diabetes mellitus, dyslipidemia, cardiovascular disorder, and cerebral stroke are systemic risk factors of RVO. However, RVO often occur in the unilateral eye and sometimes develop in young subjects who have no arteriosclerosis. In addition, RVO show different variations on the degrees of severity; some RVO are resolved without any treatment and others develop vision-threatening complications such as macular edema, combined retinal artery occlusion, vitreous hemorrhage, and glaucoma. Clinical conditions leading to RVO are still open to question. In this review, we discuss how to treat RVO in practice by presenting some RVO cases. We also deliver possible pathomechanisms of RVO through our clinical experience and animal experiments.

Publication types

  • Review

MeSH terms

  • Animals
  • Arteriosclerosis / complications
  • Arteriosclerosis / physiopathology
  • Diabetes Complications / physiopathology
  • Dyslipidemias / complications
  • Endothelin-1 / genetics*
  • Endothelin-1 / therapeutic use
  • Humans
  • Hypertension / complications
  • Hypertension / genetics
  • Retina / physiopathology*
  • Retinal Vein Occlusion / etiology
  • Retinal Vein Occlusion / genetics*
  • Retinal Vein Occlusion / physiopathology*
  • Retinal Vein Occlusion / therapy
  • Risk Factors
  • Stroke / complications
  • Veins / physiopathology

Substances

  • Endothelin-1